CVE-2020-16222

HIGHCVSS 8.8/10EPSS 0.55%

Last modified

CVE-2020-16222 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.. EPSS estimates a 0.55% chance of exploitation in the next 30 days.

Description

In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.

Metrics

CVSS 3.1
8.8/10

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
0.55%

42.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
PhilipsPatient Information Center Ixb.02
PhilipsPatient Information Center Ixc.02
PhilipsPatient Information Center Ixc.03
PhilipsPerformancebridge Focal Pointa.01

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2020-16222?
In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.
How severe is CVE-2020-16222?
CVE-2020-16222 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 0.55% probability of exploitation in the next 30 days.
How do I fix CVE-2020-16222?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2020-16222?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST